---
category: news
title: "Lantern Pharma Announces Launch of Antibody Drug Conjugate (ADC) Program to Target Solid Tumors & Blood Cancers through Agreement with Califia Pharma"
excerpt: "PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR Â® artificial intelligence (\"A.I.\") platform to transform cancer drug development and identify patients who will benefit from its targeted oncology therapeutics,"
publishedDateTime: 2021-01-04T12:30:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-announces-launch-of-antibody-drug-conjugate-adc-program-to-target-solid-tumors-blood-cancers-through-agreement-with-califia-pharma-1029930022"
webUrl: "https://markets.businessinsider.com/news/stocks/lantern-pharma-announces-launch-of-antibody-drug-conjugate-adc-program-to-target-solid-tumors-blood-cancers-through-agreement-with-califia-pharma-1029930022"
type: article

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg"
    width: 400
    height: 296
    isCached: true

secured: "te1aSLx54hwJ4TgF0dOdDDQSjFgmD7oqy8o7Xg1tW9eKgCl6GEad/yEm3jEGZPAyeO0Vkd2PKyXFyo00F/2c8e5pHO3QrRdLRkjox60s2fMHXQw4vvkgUYvtdm1/pFCyKW0YzcPPmzzdcO1TfBmq/AB32hjworb7K/PEp+ZdjtzeoG+0ZoFv32DU9jaLngAbSBIwdSaJ1SnKUCMcxfI1IS4g/HiDJoal2p7lZKlAr6928hL3DmJIwIcoJfytmFmblw3JjyeJ7x8w92grGKhnJHezKDwTr86RZb74LePh+1YBt0x+IqTud/KjCBwPHdTtXEyAicmf4Z9rNjzOgX5klrFp5Jzk15FHO0m4p+e26nA=;JNliFthZGJtqWFn7xeJD1w=="
---

